A2A Pharmaceuticals, Inc.

Insider Reports History

Entity
Company
Location
59 5 Th Ave, New York, NY
Signature
Edward Painter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by A2A Pharmaceuticals, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Biomea Fusion, Inc. 10%+ Owner Common Stock 3.5M $13.2M $3.78 Jun 1, 2023 Direct

Insider Reports Filed by A2A Pharmaceuticals, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BMEA Biomea Fusion, Inc. May 31, 2023 2 -$4.26M 4 Jun 2, 2023 10%+ Owner
BMEA Biomea Fusion, Inc. May 12, 2023 1 -$846K 4 May 17, 2023 10%+ Owner
BMEA Biomea Fusion, Inc. May 8, 2023 2 -$8.58M 4 May 10, 2023 10%+ Owner
BMEA Biomea Fusion, Inc. Apr 20, 2023 1 -$5.82M 4 Apr 26, 2023 10%+ Owner
BMEA Biomea Fusion, Inc. Mar 31, 2023 1 -$6.25M 4/A Apr 6, 2023 10%+ Owner
BMEA Biomea Fusion, Inc. Mar 31, 2023 1 $6.25M 4 Apr 6, 2023 10%+ Owner
BMEA Biomea Fusion, Inc. Aug 16, 2022 1 -$426K 4 Aug 19, 2022 10%+ Owner
BMEA Biomea Fusion, Inc. Jul 21, 2022 1 -$389K 4 Jul 25, 2022 10%+ Owner
BMEA Biomea Fusion, Inc. Jun 24, 2022 1 -$408K 4 Jun 28, 2022 10%+ Owner
BMEA Biomea Fusion, Inc. Sep 17, 2021 1 $380K 4 Sep 21, 2021 10%+ Owner